Health News

BioScrip, Inc. announced 2010 second quarter revenue of $412.0 million, operating income of $13.5 million and net income of $3.1 million, or $0.06 per diluted share. Second quarter adjusted earnings per share was $0.07 per diluted share. Adjusted ...

The partners in a new publicly-funded European research project today announced details of the multinational/multidisciplinary program: 'CSI: Central Nervous System Imaging.' This three-year ENIAC project aims to achieve substantial advances in ...

Hotspur Technologies, Inc. announced today that it has received FDA clearance for the first three commercial products in its portfolio. These products are based on Hotspur's unique and groundbreaking technology that makes dialysis access ...

Today, Formatech, Inc. announced that it has selected Femta's FM101 therapeutic candidate to be enrolled in its Fillanthropy Program. Under this program, Formatech will donate the services required to aseptically fill and finish one lot of the drug ...

Today the U.S.-India Business Council saluted Abbott Laboratories for 100 years of improving healthcare in India. In 1910, Abbott was one of the first multinationals to establish operations in India. Over the past century, Abbott has been dedicated ...

Quality Systems, Inc. today announced the results of operations for its fiscal 2011 first quarter ended June 30, 2010.

PERQ Study Shows Dental Products Report™ as a Strong Leader in Dental Publishing

As of July 30, 2010, the share capital in Diamyd Medical AB is 14,530,138.50 SEK. The total number of votes is 4,200,116 and the total number of shares is 29,060,277, divided among 1,437,876 shares of series A and 27,622,401 shares of series B .